Видео ютуба по тегу Inlyta®

What is Inlyta?
What is Inlyta?
Dr. Rini on Axitinib for Treatment of Metastatic Renal Cell Carcinoma
Dr. Rini on Axitinib for Treatment of Metastatic Renal Cell Carcinoma
Dr. Rini on the Efficacy of Axitinib and Pembrolizumab in RCC
Dr. Rini on the Efficacy of Axitinib and Pembrolizumab in RCC
INLYTA (axitinib)- advanced renal cell carcinoma (RCC)
INLYTA (axitinib)- advanced renal cell carcinoma (RCC)
NAXIVA: axitinib for reducing VTT in RCC
NAXIVA: axitinib for reducing VTT in RCC
Inlyta mechanism of action
Inlyta mechanism of action
Dr. Rini Describes Axitinib's and Sorafenib's Side Effects
Dr. Rini Describes Axitinib's and Sorafenib's Side Effects
Axitinib - INLYTA®
Axitinib - INLYTA®
Dr. Wilky on Pembrolizumab Plus Axitinib in Sarcoma
Dr. Wilky on Pembrolizumab Plus Axitinib in Sarcoma
Dr. Vaishampayan on Axitinib Plus Pembrolizumab in Advanced RCC
Dr. Vaishampayan on Axitinib Plus Pembrolizumab in Advanced RCC
Pembrolizumab monotherapy and pembro-axitinib for RCC
Pembrolizumab monotherapy and pembro-axitinib for RCC
ATLAS trial: axitinib in RCC- despite reporting no significant difference, some optimism remains
ATLAS trial: axitinib in RCC- despite reporting no significant difference, some optimism remains
Dr. Rini on Managing the Toxicity of Pembrolizumab Plus Axitinib in mRCC
Dr. Rini on Managing the Toxicity of Pembrolizumab Plus Axitinib in mRCC
Первая линия терапии метастатического рака почки. Комбинация пембролизумаб и акситиниб
Первая линия терапии метастатического рака почки. Комбинация пембролизумаб и акситиниб
Первая линия терапии метастатического рака почки. Комбинация авелумаб и акситиниб
Первая линия терапии метастатического рака почки. Комбинация авелумаб и акситиниб
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma
KEYNOTE-426: Pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma
Что назначить после первой линии таргетной терапии: Акситиниб
Что назначить после первой линии таргетной терапии: Акситиниб
Pfizer Confirms FDA Approval of Inlyta
Pfizer Confirms FDA Approval of Inlyta
Метастатический почечно-клеточный рак
Метастатический почечно-клеточный рак
Dr. Rini Describes Hypertension as a Biomarker in RCC
Dr. Rini Describes Hypertension as a Biomarker in RCC
Axitinib – INLYTA® Francois
Axitinib – INLYTA® Francois
Inlyta (Axitinib) - Drug Rx Information
Inlyta (Axitinib) - Drug Rx Information
Inlyta pelo plano de saúde: advogado explica regra da ANS para cobertura do medicamento
Inlyta pelo plano de saúde: advogado explica regra da ANS para cobertura do medicamento
Promising results for axitinib and pembrolizumab in advanced renal cell cancer
Promising results for axitinib and pembrolizumab in advanced renal cell cancer
Dr. Rini Discusses Pembrolizumab Plus Axitinib in mRCC
Dr. Rini Discusses Pembrolizumab Plus Axitinib in mRCC